title: Drug Development. Compound interests: how a partnership between academics and a drug company came unstuck.
authors.affiliation: Financial Times, London, UK. andrew.jack@ft.com
authors.forename: Andrew
authors.initials: A
authors.lastname: Jack
mesh_terms: D002986:Clinical Trials as Topic; D016265:Conflict of Interest; D003299:Cooperative Behavior; D004345:Drug Industry; D024881:Drug Resistance, Bacterial; D006801:Humans; D007373:Interinstitutional Relations; D007558:Italy; D006113:United Kingdom